Lung cancer has a high probability of metastasis to the CNS, and patients with advanced NSCLC involving driver gene alterations, such as EGFR mutations and ALK rearrangements, frequently have brain metastases (BM). Here, EGFR is linked to non-small cell lung carcinoma.